9th International Myotonic Dystrophy Consortium Meeting

第九届国际强直性肌营养不良联盟会议

• 批准号: 8651262
• 负责人: RICHARD T MOXLEY
• 金额: $ 2万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-30 至 2014-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8651262
• 关键词: Adult; Advocacy; Advocate; Affect; Age; Anesthesiology; Animal Model; Basic Science; Brain; Cardiology; Caregivers; Caring; Cell model; Clinical; Clinical Investigator; Clinical Research; Clinical Trials; Collaborations; Data; Defect; Development; Development Plans; Devices; Disease; Disease Management; Disease Progression; Endocrine system; Environment; Eye; Family Caregiver; Family Planning; Family member; Foundations; Functional disorder; Funding; Funding Agency; Future; Gene Expression Profile; Genetic; Goals; Grant; Growth; Heart; Human; Industry; Interdisciplinary Study; International; Investigational Therapies; Lead; Light; Medical Economics; Medicine; Mind; Modality; Molecular Biology; Muscle Fibers; Muscular Dystrophies; Myotonia; Myotonic Dystrophy; Neurobiology; Neurology; Neurons; Outcome Measure; Pathology; Patient Care; Patients; Peer Review; Pharmaceutical Preparations; Provider; Quality of life; RNA; Readiness; Request for Applications; Research; Research Infrastructure; Research Personnel; Schedule; Scientist; Senior Scientist; Skeletal Muscle; Spain; Structure; Symptoms; System; Therapeutic; Time; Toxic effect; Translational Research; Work; abstracting; bench to bedside; career; clinical care; efficacy testing; gastrointestinal system; induced pluripotent stem cell; innovation; lectures; medical specialties; meetings; molecular pathology; mouse model; multidisciplinary; next generation; novel strategies; optimism; patient advocacy group; patient oriented; posters; public health relevance; success; symposium; therapeutic development

Project Summary/Abstract (Description) This application requests funding for the 9th meeting of the International Myotonic Dystrophy Consortium (IDMC-9). IDMC-9 is scheduled to convene in San Sebasti¿n, Spain from October 16th to October 19th, 2013. The conference will bring together top scientists from around the world to discuss high-impact, interdisciplinary research on myotonic dystrophy (DM). The objective of the conference is to promote scientific discussion and facilitate interdisciplinary exchange. This meeting brings together leading basic researchers in the field with clinicians and clinical investigators representing a broad range of specialties including: neurology, cardiology, anesthesiology, clinical trials, neurobiology, pathology, genetics and molecular biology. Their interactions and discussions stimulate new approaches to research and clinical care and provide opportunities to develop and strengthen collaborative studies. One new focus at IDMC-9 includes plans to nurture the next-generation leaders of the field and involve them in discussions on "clinical trial preparedness." Such discussions are needed in light of promising experimental and therapeutic breakthroughs in animal models of DM. The first day of IDMC-9 will include: registration; a satellite symposium on outcome measures to assess disease progression in myotonic dystrophy; keynote lectures; and a welcoming reception. The subsequent three days of the meeting will be devoted to scientific sessions in which researchers and clinicians present peer-reviewed, selected abstracts on basic, clinical and translational research topics. The scientific sessions begin at 8:00 AM and conclude between 5:30 to 7:30 PM each day. There will be two formal poster sessions. Posters will be displayed during the entire meeting. All the sessions at IDMC-9 will focus on "cutting edge" topics and research, such as, disease mechanisms of DM, animal and cell models, clinical aspects and management of disease symptoms, and therapeutic development. On the final day, there will be patient-oriented sessions to promote discussion among patients, care-givers, representatives of patient advocacy groups, clinicians, and investigators. These sessions will be in "lay" terms to encourage interaction and exchanges of ideas among patients and investigators. The afternoon of this final day will begin with highlights from the previous sessions, followed by advocacy group presentations, and a session for questions and answers from patients and family members.

项目摘要/摘要（描述）